Effects of allopurinol treatment on the progression of chronic nephritis in canine leishmaniosis (Leishmania infantum)

Journal of Veterinary Internal Medicine

Volumn 20, Issue 2, 2006, Pages 228-233

  Plevraki, K ^a,c   Koutinas, A F ^a   Kaldrymidou, H ^a   Roumpies, N ^a   Papazoglou, L G ^a   Saridomichelakis, M N ^a   Savvas, I ^a   Leondides, L ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

^c NONE   (Greece)

Author keywords

Glomerulonephritis; Kidney; Proteinuria; Tubulointerstitial nephritis

Indexed keywords

ALLOPURINOL; ENZYME INHIBITOR;

ANIMAL; ANIMAL DISEASE; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DOG DISEASE; FEMALE; MALE; NEPHRITIS; VISCERAL LEISHMANIASIS;

ALLOPURINOL; ANIMALS; CHRONIC DISEASE; DOG DISEASES; DOGS; ENZYME INHIBITORS; FEMALE; LEISHMANIASIS, VISCERAL; MALE; NEPHRITIS;

ANIMALIA; CANIS FAMILIARIS; LEISHMANIA INFANTUM;

EID: 33645575094     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2006)20[228:EOATOT]2.0.CO;2     Document Type: Article

References (47)

1. Slappendel RJ and Ferrer L. Leishmaniasis. In: Greene CE, ed. Infectious Diseases of Dog and Cat, 2nd ed. Philadelphia, PA: WB Saunders: 1998:450-458.
2. Ciaramella P, Oliva G, Luna RD, et al. A retrospective clinical study of canine leishmaniasis in 150 dogs naturally infected by Leishmania infantum. Vet Rec 1997;141:539-543.
3. Koutinas AF, Polizopoulou ZS, Saridomichelakis MN, et al. Clinical considerations on canine visceral leishmaniasis (CVL) in Greece: A retrospective study of 158 spontaneous cases (1989-1996). J Am Anim Hosp Assoc 1999;35:376-383.
4. Benderitter TH, Casanova P, Nashkidachvili L, Quilici M. Glomerulonephritis in dogs with canine leishmaniasis. Ann Trop Med Parasitol 1988;82:335-341.
5. Koutinas AF, Kontos VI, Kaldrimidou H, Lekkas S. Canine leishmaniasis-associated nephropathy: a clinical clinicopathologic and pathologic study in 14 spontaneous cases with proteinuria. Eur J Comp Anim Pract 1995;5:31-38.
6. Nieto CG, Navarrete I, Habela MA, et al. Pathological changes in kidneys of dogs with natural Leishmania infection. Vet Parasitol 1992;45:33-47.
7. Poli A, Abramo F, Mancianti F, et al. Renal involvement in canine leishmaniasis. A light-microscopic, immunohistochemical and electron-microscopic study. Nephron 1991;57:444-452.
8. Zatelli A, Borgarelli M, Santilli R, et al. Glomerular lesions in dogs infected with Leishmania organisms. Am J Vet Res 2003;64:558-561.
9. Baneth G, Shaw SE. Chemotherapy of canine leishmaniosis. Vet Parasitol 2002;106:315-324.
10. Denerolle P, Bourdoiseau G. Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases). J Vet Intern Med 1999;13:413-415.
11. Koutinas AF, Saridomichelakis MN, Mylonakis ME, et al. A randomised, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniosis. Vet Parasitol 2001;98:247-261.
12. Moritz A, Steuber S, Greiner M. Clinical follow-up examination after treatment of canine leishmaniasis. Tokai J Exp Clin Med 1998;23:279-283.
13. Oliva G, Gradoni L, Ciaramella P, et al. Activity of liposomal amphotericin B (AmBisome) in dogs naturally infected with Leishmania infantum. J Antimicrob Chemother 1995;36:1013-1019.
14. Poli A, Sozzi S, Guidi G, et al. Comparison of aminosidine (paromomycin) and sodium stibogluconate for treatment of canine leishmaniasis. Vet Parasitol 1997;71:263-271.
15. Slappendel RJ, Teske E. The effect of intravenous or subcutaneous administration of meglumine antimonate (Glucan-time) in dogs with leishmaniasis. A randomized clinical trial. Vet Q 1997;19:10-13.
16. Gramiccia M, Gradoni L, Orsini S. Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment. Ann Trop Med Parasitol 1992;86:613-620.
17. Cavaliero T, Arnold P, Mathis A, et al. Clinical, serologic, and parasitologic follow-up after long-term allopurinol therapy of dogs naturally infected with Leishmania infantum. J Vet Intern Med 1999;13:330-334.
18. Ling GV, Ruby AL, Harrold DR, Johnson DL. Xanthine-containing urinary calculi in dogs given allopurinol. J Am Vet Med Assoc 1991;198:1935-1939.
19. Arellano F, Sacristan JA. Allopurinol hypersensitivity syndrome: A review. Ann Pharmacother 1993;27:337-343.
20. Drayer DE. Pharmacologically active drug metabolites: Therapeutic and toxic activities, plasma and urine data in man, accumulation renal failure. Clin Pharmacokinet 1976;1:426-443.
21. Paller MS. Drug-induced nephropathies. Med Clin North Am 1990;74:909-917.
22. Finco DR, Coulter DB, Barsanti JA. Simple, accurate method for clinical estimation of glomerular fitration rate in the dog. Am J Vet Res 1981;42:1874-1877.
23. Finco DR. Evaluation of renal functions. In: Osborne CA, Finco DR, eds. Canine and Feline Nephrology and Urology. Baltimore, MD: Williams & Wilkins; 1995:216-229.
24. Lott JA, Stephan VA, Pritchard KA. Evaluation of the coomassie brilliant blue G-250 method for urinary protein. Clin Chem 1983;29:1946-1950.
25. Bartles H, Bohmer M, Heirli C. Serum kreatininbestimung oline Enteiweissen. Clin Chim Acta 1972;37:193-197.
26. Chulay JD, Bryceson AD. Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. Am J Trop Med Hyg 1983;32:475-479.
27. Schwartz MM. The pathologic diagnosis of renal disease. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, eds. Heptinstall's Pathology of the Kidney, 5th ed. Philadelphia, PA: Lippincott-Raven Publishers; 1998:169-180.
28. Olson JL, Schwartz MM. The nephrotic syndrome: Minimal change disease, focal segmental glomerulosclerosis, and miscellaneous causes. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, eds. Heptinstall's Pathology of the Kidney, 5th ed. Philadelphia, PA: Lippincott-Raven Publishers; 1998:187-257.
29. Schwartz MM. Membranous glomerulonephritis. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, eds. Heptinstall's Pathology of the Kidney, 5th ed. Philadelphia, PS: Lippincott-Raven Publishers; 1998:259-307.
30. Silva FG. Membranoproliferative glomerulonephritis. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, eds. Heptinstall's Pathology of the Kidney, 5th ed. Philadelphia, PA: Lippincott-Raven Publishers; 1998:309-368.
31. Koeman JP, Biewenga WJ, Gruys E. Proteinuria in the dog: A pathomorphological study of 51 proteinuric dogs. Res Vet Sci 1987;43:367-378.
32. Mehta CR, Patel NR. SPSS Exact Tests 7.0 for Windows. Chicago: SPSS Inc; 1996.
33. Coakes SJ, Steed LG. SPSS Analysis without Anguish. Versions 7.0, 7.5, 8.0 for Windows. Brisbane, Australia: John Wiley & Sons; 1999.
34. StatXact ver. 4.0.1. Cambridge, MA: Cytel Software Corporation; 1999.
35. Palacio J, Liste F, Gascon M. Urinary protein/creatinin ratio in the evaluation of renal failure in canine leishmaniasis. Vet Rec 1995;137:567-568.
36. Dutra M, Martinelli R, de Carvalho EM, et al. Renal involvement in visceral leishmaniasis. Am J Kidney Dis 1985;6:22-27.
37. Lulich JP, Osborne CA. Interpretation of urine protein-creatinine ratios in dogs with glomerular and nonglomerular disorders. Comp Cont Ed Pract Vet 1990;12:59-73.
38. Brown SA. Primary diseases of glomeruli. In: Osborne CA, Finco DR, eds. Canine and Feline Nephrology and Urology. Baltimore, MD: Wiliams & Wilkins; 1995:368-385.
39. Finco DR. Urinary protein loss. In: Osborne CA, Finco DR, eds. Canine and Feline Nephrology and Urology. Baltimore, MD: Williams & Wilkins; 1995:211-215.
40. DiBartola SP, Spaulding GL, Chew DJ, Lewis RM. Urinary protein excretion and immunopathologic findings in dogs with glomerular disease. J Am Vet Med Assoc 1980;177:73-77.
41. Hurley KJ, Vaden SL. Proteinuria in dogs and cats: A diagnostic approach. In: Bonagura JD, ed. Kirk's Current Veterinary Therapy - Small Animal Practice XII. Philadelphia, PA: WB Saunders; 1995:937-940.
42. Plumb DC. Veterinary Drug Handbook, 3rd ed. Ames, IA: Iowa State University Press; 1999:16-18.
43. Cotran RS, Kumar V, Collins T. The kidney. In: Cotran RS, Kumar V, Collins T, eds. Pathologic Basis of Disease, 6th ed. Philadelphia, PA: WB Saunders; 2002:930-996.
44. Remuzzi G, Ruggenenti P, Benigni A. Understanding the nature of renal disease progression. Kidney Int 1997;51:2-15.
45. Schena FP, Gesualdo L, Grandaliano G, Mantinaro V. Progression of renal damage in human glomerulonephritis: Is there sleight of hand in winning the game? Kidney Int 1997;52:1439-1457.
46. Duarte MI, Silva MR, Goto H, et al. Interstitial nephritis in human kala-azar. Trans R Soc Trop Med Hyg 1983;77:531-537.
47. Houba V. Immunologic aspects of renal lesions associated with malaria. Kidney Int 1979;16:3-8.